Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berta Luzón-Toro

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Nuclear Medicine and Biology|October 14, 2008
Hydroxytyrosol increases norepinephrine transporter function in pheochromocytoma cellsBerta Luzón-Toro, Arjan Geerlings, Sabine Hilfiker
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 5, 2006
Gas chromatographic-mass spectrometric determination of brain levels of alpha-cholest-8-en-3beta-ol (lathosterol)Berta Luzón-Toro, Alberto Zafra-Gómez, Oscar Ballesteros
International Journal of Molecular Sciences|June 29, 2019
Epigenetic Mechanisms in Hirschsprung DiseaseAna Torroglosa, Leticia Villalba-Benito, Berta Luzón-Toro, et al.
Human Molecular Genetics|June 23, 2007
Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutationBerta Luzón-Toro, Elena Rubio de la Torre, Asunción Delgado, et al.
Orphanet Journal of Rare Diseases|January 7, 2021
RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancerBerta Luzón-Toro, Leticia Villalba-Benito, Raquel María Fernández, et al.
Clinical Genetics|July 30, 2019
What is new about the genetic background of Hirschsprung disease?Berta Luzón-Toro, Leticia Villalba-Benito, Ana Torroglosa, et al.
Genes|November 14, 2019
Influencers on Thyroid Cancer Onset: Molecular Genetic BasisBerta Luzón-Toro, Raquel María Fernández, Leticia Villalba-Benito, et al.
BMC Medical Genetics|October 7, 2015
Next-generation-based targeted sequencing as an efficient tool for the study of the genetic background in Hirschsprung patientsBerta Luzón-Toro, Laura Espino-Paisán, Raquel Ma Fernández, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 6, 2011
Novel mutations at RET ligand genes preventing receptor activation are associated to Hirschsprung's diseaseMacarena Ruiz-Ferrer, Ana Torroglosa, Berta Luzón-Toro, et al.
Human Molecular Genetics|December 4, 2008
Combined kinase inhibition modulates parkin inactivationElena Rubio de la Torre, Berta Luzón-Toro, Irene Forte-Lago, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Nuclear Medicine and Biology|October 14, 2008
Hydroxytyrosol increases norepinephrine transporter function in pheochromocytoma cellsBerta Luzón-Toro, Arjan Geerlings, Sabine Hilfiker
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 5, 2006
Gas chromatographic-mass spectrometric determination of brain levels of alpha-cholest-8-en-3beta-ol (lathosterol)Berta Luzón-Toro, Alberto Zafra-Gómez, Oscar Ballesteros
International Journal of Molecular Sciences|June 29, 2019
Epigenetic Mechanisms in Hirschsprung DiseaseAna Torroglosa, Leticia Villalba-Benito, Berta Luzón-Toro, et al.
Human Molecular Genetics|June 23, 2007
Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutationBerta Luzón-Toro, Elena Rubio de la Torre, Asunción Delgado, et al.
Orphanet Journal of Rare Diseases|January 7, 2021
RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancerBerta Luzón-Toro, Leticia Villalba-Benito, Raquel María Fernández, et al.
Clinical Genetics|July 30, 2019
What is new about the genetic background of Hirschsprung disease?Berta Luzón-Toro, Leticia Villalba-Benito, Ana Torroglosa, et al.
Genes|November 14, 2019
Influencers on Thyroid Cancer Onset: Molecular Genetic BasisBerta Luzón-Toro, Raquel María Fernández, Leticia Villalba-Benito, et al.
BMC Medical Genetics|October 7, 2015
Next-generation-based targeted sequencing as an efficient tool for the study of the genetic background in Hirschsprung patientsBerta Luzón-Toro, Laura Espino-Paisán, Raquel Ma Fernández, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 6, 2011
Novel mutations at RET ligand genes preventing receptor activation are associated to Hirschsprung's diseaseMacarena Ruiz-Ferrer, Ana Torroglosa, Berta Luzón-Toro, et al.
Human Molecular Genetics|December 4, 2008
Combined kinase inhibition modulates parkin inactivationElena Rubio de la Torre, Berta Luzón-Toro, Irene Forte-Lago, et al.
Pageof 3